Position in RPRX
as of Mar 31, 2026
· filed May 21, 2026
Position Value
$4,014,513
+$3,550,833 QoQ
Shares Held
83,688
+597.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VESTOR CAPITAL, LLC holds $13,615,068 across 6 Biotechnology names. RPRX ranks #2 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,655 | $9,005,119 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
83,688 | $4,014,513 | |
| 3 | JUNS |
Jupiter Neurosciences, Inc.
|
970,985 | $365,090 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
202 | $90,201 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
11,536 | $88,481 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
200 | $51,664 |
All Filings in RPRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,014,513 | 83,688 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $463,680 | 12,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,896,981 | 82,114 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $203,065 | 5,636 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $12,599,431 | 404,736 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||